Calidi Biotherapeutics, Inc. (AMEX: CLDI) last traded at $1.03, down 0.96% on the session. The quote above updates while this page is open; the figures below are drawn from Calidi Biotherapeutics, Inc.’s own filings and are restated only when a new one is published.
Calidi Biotherapeutics, Inc. trades on AMEX under the ticker CLDI. Its market capitalisation is $2.66 million.
Valuation measures for Calidi Biotherapeutics, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $2.66M |
|---|---|
| Enterprise value | $2.44M |
| Price / book | 0.85 |
| Beta | 2.23 |
Trailing-twelve-month figures tagged in Calidi Biotherapeutics, Inc.'s XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$17.40M |
| Return on equity | -555.28% |
|---|
| Cash | $4.29M |
|---|
Range and volume for CLDI over the past 52 weeks.
| 52-week high | $27.84 |
|---|---|
| 52-week low | $0.986 |
| Volume | 17.9K |
| Average volume | 255.8K |
| Previous close | $1.04 |
Invest a chosen dollar amount in Calidi Biotherapeutics, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CLDI.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.